Forward, Faster

We focus on delivering best-in-class medicines with transformational impact for patients by accelerating life-changing science and innovation in the fields of immunology and oncology

In 2022, we unveiled a new strategy to accelerate growth and value creation by reshaping the way we innovate and operate.
This strategy provides a clear path forward based on four key pillars.

Pillar One

Pioneering for patients

At Galapagos, we know that patients in need are waiting. That is why we focus on therapeutic areas where we aim to make transformational impact happen faster, including
oncology and immunology.

Pillar Two

Diversifying and accelerating our pipeline

To maximize our success in developing and delivering best-in-class medicines, we work with multiple drug modalities and combinations and apply deep disease expertise with the aim to
reduce risk.

Pillar Three

Collaborating and partnering for greater impact

Science is more complex than ever. To accelerate the development of best-in-class medicines, our unique innovation model brings the best science, technology, and biological capabilities inside and outside our company. We are also investing in partnerships and technologies with the potential to change treatment paradigms.

Pillar Four

Making it happen, together, as a team

We are #PioneeringForPatients, together! Today, we are building on our foundation and continuing our mission of living innovation by focusing our efforts on immunology, oncology and other therapeutic areas where we can best accelerate the development of innovative new therapies with transformational impact for patients. Tomorrow, we will do even more to redefine what is possible for our patients and our shareholders.

Forward, sustainably

Caring for our future

Our Sustainability call to action for 2028, which we know as ‘Forward, Sustainably’, describes our ambition for patients, the healthcare community and system, our workforce, our planet. You’ll want to know more!

Work with us

We are looking for partners

Our unique innovation model leverages the best scientific, technological and biological capabilities inside and outside our company, while fostering strong partnerships with biotech and pharmaceutical companies, leading academic institutions and patient organizations.

We seek new licensing opportunities and partnerships to build our pipeline.

News

Stay up to date

Follow the latest on our journey, as we are living innovation!

Investors

The full picture

Looking for the latest presentations, upcoming events and financial highlights?